Platelet BioGenesis
Producing the world’s first donor-independent human platelets.
Launch date
Employees
Market cap
-
Enterprise valuation
€275—412m (Dealroom.co estimates Nov 2021.)
Cambridge Massachusetts (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$3.5m | Grant | ||
| N/A | N/A | Series A | |
$26.0m | Series A | ||
$2.3m | Grant | ||
$75.5m | Series B | ||
| Total Funding | €107m | ||
Related Content
Recent News about Platelet BioGenesis
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.